| Chemical | Toxicity Endpoint Type | Endpoint Description | Endpoint Value | Sample Size | Life Cycle Stage | Study Duration | Type |
|---|---|---|---|---|---|---|---|
| CRUDE OILS | TOX-REPRO - reproductive success | percent mortality versus controls | increase @ 2-15 ul/egg | 100 eggs/dose | Embryo | 16 d | Toxicity Factor Datasets |
| CRUDE OILS | TOX-REPRO - development | incidence of survivors with abnormalities versus controls | increase @ 2-15 ul/egg | 100 eggs/dose | Embryo | 16 d | Toxicity Factor Datasets |
| CRUDE OILS | TOX-REPRO - physiology | red blood cell and liver ALAD activity and hemoglobin concentration, compared to controls | decrease @ 15 ul/egg | 100 eggs/dose | Embryo | 14 d | Toxicity Factor Datasets |
| CRUDE OILS | TOX-REPRO - physiology | red blood cell and liver ALAD activity, hemoglobin concentration, plasma uric acid, and plasma ALT and AST activities compared to controls | decrease @ 5, 15 ul/egg | 100 eggs/dose | Hatchling | 23 d | Toxicity Factor Datasets |
